Raghuraman Kannan

Raghuraman Kannan

University of Missouri

H-index: 35

North America-United States

About Raghuraman Kannan

Raghuraman Kannan, With an exceptional h-index of 35 and a recent h-index of 24 (since 2020), a distinguished researcher at University of Missouri, specializes in the field of Oncology, Drug Delivery Vehicle, Theranostics, Gene Therapy, Repurposing Drugs in Oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Nano gelasomes: Novel lamellar metal-protein suprastructures for nucleic acid delivery

Enhanced cancer therapy strategies utilizing gelatin-lipidoid hybrid nanoparticles for RNA delivery

Exploring the implications of LPAR-1 expression in TKI-resistant NSCLC

Unaccounted microplastics in the outlet of wastewater treatment plants—challenges and opportunities

Compositions for the treatment of drug-resistant tumors and methods of use thereof

Engineering biomolecular systems: Controlling the self-assembly of gelatin to form ultra-small bioactive nanomaterials

Peptides for molecular detection of PD-L1

Identification and Validation of Biomarkers for Early Detection of Diabetic Retinopathy

Raghuraman Kannan Information

University

Position

Professor of Radiology and Bioengineering

Citations(all)

5245

Citations(since 2020)

1839

Cited By

4426

hIndex(all)

35

hIndex(since 2020)

24

i10Index(all)

66

i10Index(since 2020)

41

Email

University Profile Page

Google Scholar

Raghuraman Kannan Skills & Research Interests

Oncology

Drug Delivery Vehicle

Theranostics

Gene Therapy

Repurposing Drugs in Oncology

Top articles of Raghuraman Kannan

Nano gelasomes: Novel lamellar metal-protein suprastructures for nucleic acid delivery

Cancer Research

2024/3/22

Zhaohui Li
Zhaohui Li

H-Index: 58

Raghuraman Kannan
Raghuraman Kannan

H-Index: 26

Enhanced cancer therapy strategies utilizing gelatin-lipidoid hybrid nanoparticles for RNA delivery

Cancer Research

2024/3/22

Exploring the implications of LPAR-1 expression in TKI-resistant NSCLC

Cancer Research

2024/3/22

Zhaohui Li
Zhaohui Li

H-Index: 58

Raghuraman Kannan
Raghuraman Kannan

H-Index: 26

Unaccounted microplastics in the outlet of wastewater treatment plants—challenges and opportunities

2023/3/8

Abilash Gangula
Abilash Gangula

H-Index: 4

Raghuraman Kannan
Raghuraman Kannan

H-Index: 26

Compositions for the treatment of drug-resistant tumors and methods of use thereof

2023/2/14

Engineering biomolecular systems: Controlling the self-assembly of gelatin to form ultra-small bioactive nanomaterials

Bioactive Materials

2022/12/1

Agasthya Suresh
Agasthya Suresh

H-Index: 2

Raghuraman Kannan
Raghuraman Kannan

H-Index: 26

Peptides for molecular detection of PD-L1

2022/9/20

Identification and Validation of Biomarkers for Early Detection of Diabetic Retinopathy

Investigative Ophthalmology & Visual Science

2022/6/1

Abilash Gangula
Abilash Gangula

H-Index: 4

Raghuraman Kannan
Raghuraman Kannan

H-Index: 26

Targeted doxorubicin-gold nanoconjugates for tumor therapy

2022/2/16

Wastewater treatment using novel magnetic nanosponges

Water

2022/2/8

Raghuraman Kannan
Raghuraman Kannan

H-Index: 26

Controlled assembly of gold and albumin nanoparticles to form hybrid multimeric nanomaterials

Polymers for Advanced Technologies

2022/2

Raghuraman Kannan
Raghuraman Kannan

H-Index: 26

Developmental exposure to silver nanoparticles leads to long term gut dysbiosis and neurobehavioral alterations

Scientific Reports

2021/3/22

Raghuraman Kannan
Raghuraman Kannan

H-Index: 26

Trupti Joshi
Trupti Joshi

H-Index: 30

A review on RNAi therapy for NSCLC: Opportunities and challenges

2021/3

Sairam Yadavilli
Sairam Yadavilli

H-Index: 2

Raghuraman Kannan
Raghuraman Kannan

H-Index: 26

Targeted Doxorubicin-Gold Nanocojugates for Tumor Therapy

2021/1/21

A novel crosslinker‐free technique toward the fabrication of collagen microspheres

Journal of Biomedical Materials Research Part B: Applied Biomaterials

2020/10

Raghuraman Kannan
Raghuraman Kannan

H-Index: 26

Sheila Grant
Sheila Grant

H-Index: 19

Magnetic iron nanocubes effectively capture epithelial and mesenchymal cancer cells

ACS omega

2020/9/9

Plate-adherent nanosubstrate for improved ELISA of small molecules: A proof of concept study

Analytical Chemistry

2020/7/22

Abilash Gangula
Abilash Gangula

H-Index: 4

Raghuraman Kannan
Raghuraman Kannan

H-Index: 26

Systematic evaluation of protein-based nanoparticles for stable delivery of small interfering RNA

Journal of Biomedical Nanotechnology

2020/7/1

Brian Jenkins
Brian Jenkins

H-Index: 6

Raghuraman Kannan
Raghuraman Kannan

H-Index: 26

Process to determine efficacy of single human antibody type nanoparticle conjugate

2020/5/7

Laboratory tests for COVID-19: a review of peer-reviewed publications and implications for clinical use

2020/5

See List of Professors in Raghuraman Kannan University(University of Missouri)